EUVIMEDEUVIMED entdecken
Crossref

miR‐5701 Drives Bone Fracture Repair in Osteoporosis Through TP53 Regulation

Sinan Liu, Yuan Ruan, Ganggang Wang iD, Ningning Zhang iD, Huiling Qin iD

APMIS · 2026

DOI: 10.1111/apm.70153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2026. Verfasst von Sinan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Medicine, University of Sanya, Sanya, China. Hauptthemen laut MEDLINE: MicroRNAs, Tumor Suppressor Protein p53, Osteoporosis, Fracture Healing. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study identified miR‐5701 and TP53 through bioinformatics analysis utilizing the GEO, GeneCards, and miRDB databases. The serum expression levels were quantified via Reverse Transcription Quantitative Real‐time Polymerase Chain Reaction (RT‐qPCR). The binding relationship between miR‐5701 and TP53 was confirmed using dual luciferase reporter assays. Subsequently, MC3T3‐E1 cell differentiation was induced with Bone Morphogenetic Protein 2 (BMP2), and the expression changes of miR‐5701 and TP53 after cell differentiation were detected. Subsequently, after overexpression of miR‐5701 and TP53, the expression levels of key osteogenic differentiation markers Alkaline Phosphatase (ALP), Osteocalcin (OCN), and type I collagen were evaluated by ELISA. Serum miR‐5701 expression is downregulated in osteoporotic fracture patients, while it increases after osteoblast differentiation. TP53 is a negative regulatory binding factor downstream of miR‐5701. The mRNA expression of TP53 in the patient serum and the differentiated osteoblast cells is exactly opposite to that of miR‐5701. Overexpression of miR‐5701‐mediated promotion of osteoblast proliferation and differentiation can be reversed by TP53. miR‐5701 was found to facilitate osteoblast proliferation and differentiation through negative regulation of the target gene TP53 expression, suggesting that miR‐5701 could serve as a promising therapeutic target for promoting fracture healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsTumor Suppressor Protein p53OsteoporosisFracture HealingOsteoporotic FracturesHumansOsteoblastsAnimalsCell DifferentiationMiceOsteogenesisGene Expression RegulationCell ProliferationCell LineOsteocalcinBone Morphogenetic Protein 2Female

Stichwörter der Autor:innen

TP53fracture healingmiR‐5701osteogenic differentiationosteoporosis

Substanzen

MicroRNAsTumor Suppressor Protein p53TP53 protein, humanOsteocalcinBone Morphogenetic Protein 2

Autor:innen und Institutionen

  • School of Health Medicine, University of Sanya, Sanya, China.
  • Department of Orthopedics, Huanggang Central Hospital, Huanggang, China.
  • Department of Hand and Foot Surgery, Zhucheng People's Hospital, Weifang, China.
  • Department of Orthopedics, Affiliated Hospital of Hebei University of Engineering, Handan, China.
  • Department of Rehabilitation, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
  • Guangxi Key Laboratory for Preclinical and Translational Research on Bone and Joint Degenerative Diseases, Baise, Guangxi, China.

ORCID-Profile: Ganggang Wang, Ningning Zhang, Huiling Qin

Zitieren

APA

Liu, S., Ruan, Y., Wang, G., Zhang, N., & Qin, H. (2026). miR‐5701 Drives Bone Fracture Repair in Osteoporosis Through TP53 Regulation. APMIS. https://doi.org/10.1111/apm.70153

Vancouver

Liu S, Ruan Y, Wang G, Zhang N, Qin H. miR‐5701 Drives Bone Fracture Repair in Osteoporosis Through TP53 Regulation. APMIS. 2026. doi:10.1111/apm.70153

BibTeX
@article{Liu2026,
  author = {Liu, Sinan and Ruan, Yuan and Wang, Ganggang and Zhang, Ningning and Qin, Huiling},
  title = {miR‐5701 Drives Bone Fracture Repair in Osteoporosis Through TP53 Regulation},
  journal = {APMIS},
  year = {2026},
  doi = {10.1111/apm.70153}
}
Kostenlos starten →